Isabel Brosius

Isabel Brosius is a researcher affiliated with the Institute of Tropical Medicine Antwerp (ITM) in Belgium. Her work focuses on tropical medicine, virology, and infectious disease epidemiology. She holds a Master’s degree and has contributed to high-impact studies on monkeypox (mpox), schistosomiasis, and SARS-CoV-2 immunology. Brosius leads the 'Scabies1' project (2023–2025), investigating rising scabies cases in Flanders. She has published extensively in journals like The Lancet and Nature Medicine, with recent work analyzing mpox outbreaks in the Democratic Republic of the Congo and evaluating antimalarial treatments for schistosomiasis in children.

Her research spans viral epidemiology, drug efficacy trials, and public health interventions. Brosius collaborates with global institutions, addressing emerging pathogens and tropical diseases. Key contributions include insights into mpox transmission dynamics, cytokine profiles in viral infections, and long-term outcomes of infectious diseases. Funding includes grants from the Flemish Government’s Agency for Care & Health.